RAPT Therapeutics (RAPT)
NASDAQ:RAPT
Holding RAPT?
Track your performance easily

RAPT Therapeutics (RAPT) Financial Statements

297 Followers

RAPT Therapeutics Financial Overview

RAPT Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.124; its P/E ratio is -0.60; RAPT Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -27.66M$ -32.52M$ -33.92M$ -25.28M$ -29.27M
EBITDA$ -26.38M$ -32.20M$ -33.59M$ -26.52M$ -30.41M
Net Income Common Stockholders$ -27.66M$ -30.52M$ -31.37M$ -25.28M$ -29.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 114.84M$ 141.58M$ 184.78M$ 205.00M$ 231.63M
Total Assets$ 127.18M$ 155.82M$ 199.72M$ 220.76M$ 248.33M
Total Debt$ 5.73M$ 6.32M$ 7.46M$ 8.00M$ 8.53M
Net Debt$ -109.11M$ -135.26M$ -177.31M$ -197.00M$ -223.10M
Total Liabilities$ 17.96M$ 24.98M$ 26.92M$ 21.08M$ 27.86M
Stockholders Equity$ 109.22M$ 130.84M$ 172.80M$ 199.68M$ 220.47M
Cash Flow-
Free Cash Flow$ -28.15M$ -27.19M$ -21.95M$ -29.04M$ -19.36M
Operating Cash Flow$ -28.15M$ -27.08M$ -21.88M$ -28.81M$ -18.60M
Investing Cash Flow$ 19.21M$ 15.89M$ 25.75M$ 32.44M$ 25.31M
Financing Cash Flow$ 701.00K$ 9.04M$ 106.00K$ 767.00K$ 116.00K
Currency in USD

RAPT Therapeutics Earnings and Revenue History

RAPT Therapeutics Debt to Assets

RAPT Therapeutics Cash Flow

RAPT Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis